Global Microbiome Therapeutics Market Intelligence Report for Comprehensive Information 2017-2025

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Aug-2018   |    Format :PDF   |    Number of Pages : 123
This report studies the global Microbiome Therapeutics market status and forecast, categorizes the global Microbiome Therapeutics market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult). 
These microbes are generally not harmful to us; in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes. 
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.

In the last several years, global market of Microbiome Therapeutics developed rapidly, with an average growth rate of 98%. In 2017, Global Market Size of Microbiome Therapeutics is nearly 14 M USD. 
For developing product, there are 2 products in Phase 3, 7 products in Phase 2, 8 products in Phase 1 and 17 products in Preclinical. The total investment for Microbiome Therapeutics developing is around 293 M USD in 2017.
The Application of Microbiome Therapeutics includes CDI, IBD, Orphan Drug, Immuno-oncology and Others, and the proportion of R&D Investmen for CDI in 2016 is about 52%, and the proportion is in Increase trend from 2012 to 2016.
The global Microbiome Therapeutics market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major manufacturers covered in this report
    Seres Therapeutics
    Assembly Biosciences
    Synthetic Biologics
    Interxon
    PureTech
    Synlogic
    Enterome BioScience
    4D Pharma
    Second Genome
    AOBiome
    C3 Jian
    Rebiotix
    MicroBiome Therapeutics LLC
    Metabiomics
    Ritter Pharmaceuticals
    Symberix
    OpenBiome
    Azitra
    Symbiotix Biotherapies
    Osel
    Metabogen

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
    North America
    Europe
    China
    Japan
    India
    Southeast Asia
    Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Rest of Asia-Pacific
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
        Rest of Europe
    Central & South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Saudi Arabia
        Turkey
        Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Type I
    Type II

By Application, the market can be split into
    Inflammatory Bowel Disease (IBD)
    Orphan Drug
    Immuno-oncology
    Others

The study objectives of this report are:
    To analyze and study the global Microbiome Therapeutics capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
    Focuses on the key Microbiome Therapeutics manufacturers, to study the capacity, production, value, market share and development plans in future.
    Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
    To define, describe and forecast the market by type, application and region.
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends and factors driving or inhibiting the market growth.
    To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
    To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Microbiome Therapeutics are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Microbiome Therapeutics Manufacturers
Microbiome Therapeutics Distributors/Traders/Wholesalers
Microbiome Therapeutics Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Microbiome Therapeutics market, by end-use.
Detailed analysis and profiles of additional market players.

Global Microbiome Therapeutics Market Professional Survey Report 2018
1 Industry Overview of Microbiome Therapeutics
    1.1 Definition and Specifications of Microbiome Therapeutics
        1.1.1 Definition of Microbiome Therapeutics
        1.1.2 Specifications of Microbiome Therapeutics
    1.2 Classification of Microbiome Therapeutics
        1.2.1 Type I
        1.2.2 Type II
    1.3 Applications of Microbiome Therapeutics
        1.3.1 Inflammatory Bowel Disease (IBD)
        1.3.2 Orphan Drug
        1.3.3 Immuno-oncology
        1.3.4 Others
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 Europe
        1.4.3 China
        1.4.4 Japan
        1.4.5 Southeast Asia
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Microbiome Therapeutics
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Microbiome Therapeutics
    2.3 Manufacturing Process Analysis of Microbiome Therapeutics
    2.4 Industry Chain Structure of Microbiome Therapeutics

3 Technical Data and Manufacturing Plants Analysis of Microbiome Therapeutics
    3.1 Capacity and Commercial Production Date of Global Microbiome Therapeutics Major Manufacturers in 2017
    3.2 Manufacturing Plants Distribution of Global Microbiome Therapeutics Major Manufacturers in 2017
    3.3 R&D Status and Technology Source of Global Microbiome Therapeutics Major Manufacturers in 2017
    3.4 Raw Materials Sources Analysis of Global Microbiome Therapeutics Major Manufacturers in 2017

4 Global Microbiome Therapeutics Overall Market Overview
    4.1 2013-2018E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2013-2018E Global Microbiome Therapeutics Capacity and Growth Rate Analysis
        4.2.2 2017 Microbiome Therapeutics Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2013-2018E Global Microbiome Therapeutics Sales and Growth Rate Analysis
        4.3.2 2017 Microbiome Therapeutics Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2013-2018E Global Microbiome Therapeutics Sales Price
        4.4.2 2017 Microbiome Therapeutics Sales Price Analysis (Company Segment)

5 Microbiome Therapeutics Regional Market Analysis
    5.1 North America Microbiome Therapeutics Market Analysis
        5.1.1 North America Microbiome Therapeutics Market Overview
        5.1.2 North America 2013-2018E Microbiome Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2013-2018E Microbiome Therapeutics Sales Price Analysis
        5.1.4 North America 2017 Microbiome Therapeutics Market Share Analysis
    5.2 Europe Microbiome Therapeutics Market Analysis
        5.2.1 Europe Microbiome Therapeutics Market Overview
        5.2.2 Europe 2013-2018E Microbiome Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 Europe 2013-2018E Microbiome Therapeutics Sales Price Analysis
        5.2.4 Europe 2017 Microbiome Therapeutics Market Share Analysis
    5.3 China Microbiome Therapeutics Market Analysis
        5.3.1 China Microbiome Therapeutics Market Overview
        5.3.2 China 2013-2018E Microbiome Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 China 2013-2018E Microbiome Therapeutics Sales Price Analysis
        5.3.4 China 2017 Microbiome Therapeutics Market Share Analysis
    5.4 Japan Microbiome Therapeutics Market Analysis
        5.4.1 Japan Microbiome Therapeutics Market Overview
        5.4.2 Japan 2013-2018E Microbiome Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Japan 2013-2018E Microbiome Therapeutics Sales Price Analysis
        5.4.4 Japan 2017 Microbiome Therapeutics Market Share Analysis
    5.5 Southeast Asia Microbiome Therapeutics Market Analysis
        5.5.1 Southeast Asia Microbiome Therapeutics Market Overview
        5.5.2 Southeast Asia 2013-2018E Microbiome Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Southeast Asia 2013-2018E Microbiome Therapeutics Sales Price Analysis
        5.5.4 Southeast Asia 2017 Microbiome Therapeutics Market Share Analysis
    5.6 India Microbiome Therapeutics Market Analysis
        5.6.1 India Microbiome Therapeutics Market Overview
        5.6.2 India 2013-2018E Microbiome Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2013-2018E Microbiome Therapeutics Sales Price Analysis
        5.6.4 India 2017 Microbiome Therapeutics Market Share Analysis

6 Global 2013-2018E Microbiome Therapeutics Segment Market Analysis (by Type)
    6.1 Global 2013-2018E Microbiome Therapeutics Sales by Type
    6.2 Different Types of Microbiome Therapeutics Product Interview Price Analysis
    6.3 Different Types of Microbiome Therapeutics Product Driving Factors Analysis
        6.3.1 Type I Growth Driving Factor Analysis
        6.3.2 Type II Growth Driving Factor Analysis

7 Global 2013-2018E Microbiome Therapeutics Segment Market Analysis (by Application)
    7.1 Global 2013-2018E Microbiome Therapeutics Consumption by Application
    7.2 Different Application of Microbiome Therapeutics Product Interview Price Analysis
    7.3 Different Application of Microbiome Therapeutics Product Driving Factors Analysis
        7.3.1 Inflammatory Bowel Disease (IBD) of Microbiome Therapeutics Growth Driving Factor Analysis
        7.3.2 Orphan Drug of Microbiome Therapeutics Growth Driving Factor Analysis
        7.3.3 Immuno-oncology of Microbiome Therapeutics Growth Driving Factor Analysis
        7.3.4 Others of Microbiome Therapeutics Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Microbiome Therapeutics
    8.1 Seres Therapeutics
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Seres Therapeutics 2017 Microbiome Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Seres Therapeutics 2017 Microbiome Therapeutics Business Region Distribution Analysis
    8.2 Assembly Biosciences
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Assembly Biosciences 2017 Microbiome Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Assembly Biosciences 2017 Microbiome Therapeutics Business Region Distribution Analysis
    8.3 Synthetic Biologics
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Synthetic Biologics 2017 Microbiome Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Synthetic Biologics 2017 Microbiome Therapeutics Business Region Distribution Analysis
    8.4 Interxon
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Interxon 2017 Microbiome Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Interxon 2017 Microbiome Therapeutics Business Region Distribution Analysis
    8.5 PureTech
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 PureTech 2017 Microbiome Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 PureTech 2017 Microbiome Therapeutics Business Region Distribution Analysis
    8.6 Synlogic
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Synlogic 2017 Microbiome Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Synlogic 2017 Microbiome Therapeutics Business Region Distribution Analysis
    8.7 Enterome BioScience
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Enterome BioScience 2017 Microbiome Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Enterome BioScience 2017 Microbiome Therapeutics Business Region Distribution Analysis
    8.8 4D Pharma
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 4D Pharma 2017 Microbiome Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 4D Pharma 2017 Microbiome Therapeutics Business Region Distribution Analysis
    8.9 Second Genome
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Second Genome 2017 Microbiome Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Second Genome 2017 Microbiome Therapeutics Business Region Distribution Analysis
    8.10 AOBiome
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 AOBiome 2017 Microbiome Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 AOBiome 2017 Microbiome Therapeutics Business Region Distribution Analysis
    8.11 C3 Jian
    8.12 Rebiotix
    8.13 MicroBiome Therapeutics LLC
    8.14 Metabiomics
    8.15 Ritter Pharmaceuticals
    8.16 Symberix
    8.17 OpenBiome
    8.18 Azitra
    8.19 Symbiotix Biotherapies
    8.20 Osel
    8.21 Metabogen

9 Development Trend of Analysis of Microbiome Therapeutics Market
    9.1 Global Microbiome Therapeutics Market Trend Analysis
        9.1.1 Global 2018-2025 Microbiome Therapeutics Market Size (Volume and Value) Forecast
        9.1.2 Global 2018-2025 Microbiome Therapeutics Sales Price Forecast
    9.2 Microbiome Therapeutics Regional Market Trend
        9.2.1 North America 2018-2025 Microbiome Therapeutics Consumption Forecast
        9.2.2 Europe 2018-2025 Microbiome Therapeutics Consumption Forecast
        9.2.3 China 2018-2025 Microbiome Therapeutics Consumption Forecast
        9.2.4 Japan 2018-2025 Microbiome Therapeutics Consumption Forecast
        9.2.5 Southeast Asia 2018-2025 Microbiome Therapeutics Consumption Forecast
        9.2.6 India 2018-2025 Microbiome Therapeutics Consumption Forecast
    9.3 Microbiome Therapeutics Market Trend (Product Type)
    9.4 Microbiome Therapeutics Market Trend (Application)

10 Microbiome Therapeutics Marketing Type Analysis
    10.1 Microbiome Therapeutics Regional Marketing Type Analysis
    10.2 Microbiome Therapeutics International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Microbiome Therapeutics by Region
    10.4 Microbiome Therapeutics Supply Chain Analysis

11 Consumers Analysis of Microbiome Therapeutics
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Microbiome Therapeutics Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source



List of Tables and Figures
    Figure Picture of Microbiome Therapeutics
    Table Product Specifications of Microbiome Therapeutics
    Table Classification of Microbiome Therapeutics
    Figure Global Production Market Share of Microbiome Therapeutics by Type in 2017
    Figure Type I Picture
    Table Major Manufacturers of Type I
    Figure Type II Picture
    Table Major Manufacturers of Type II
    Table Applications of Microbiome Therapeutics
    Figure Global Consumption Volume Market Share of Microbiome Therapeutics by Application in 2017
    Figure Inflammatory Bowel Disease (IBD) Examples
    Table Major Consumers in Inflammatory Bowel Disease (IBD)
    Figure Orphan Drug Examples
    Table Major Consumers in Orphan Drug
    Figure Immuno-oncology Examples
    Table Major Consumers in Immuno-oncology
    Figure Others Examples
    Table Major Consumers in Others
    Figure Market Share of Microbiome Therapeutics by Regions
    Figure North America Microbiome Therapeutics Market Size (Million USD) (2013-2025)
    Figure Europe Microbiome Therapeutics Market Size (Million USD) (2013-2025)
    Figure China Microbiome Therapeutics Market Size (Million USD) (2013-2025)
    Figure Japan Microbiome Therapeutics Market Size (Million USD) (2013-2025)
    Figure Southeast Asia Microbiome Therapeutics Market Size (Million USD) (2013-2025)
    Figure India Microbiome Therapeutics Market Size (Million USD) (2013-2025)
    Table Microbiome Therapeutics Raw Material and Suppliers
    Table Manufacturing Cost Structure Analysis of Microbiome Therapeutics in 2017
    Figure Manufacturing Process Analysis of Microbiome Therapeutics
    Figure Industry Chain Structure of Microbiome Therapeutics
    Table Capacity and Commercial Production Date of Global Microbiome Therapeutics Major Manufacturers in 2017
    Table Manufacturing Plants Distribution of Global Microbiome Therapeutics Major Manufacturers in 2017
    Table R&D Status and Technology Source of Global Microbiome Therapeutics Major Manufacturers in 2017
    Table Raw Materials Sources Analysis of Global Microbiome Therapeutics Major Manufacturers in 2017
    Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Microbiome Therapeutics 2013-2018E
    Figure Global 2013-2018E Microbiome Therapeutics Market Size (Volume) and Growth Rate
    Figure Global 2013-2018E Microbiome Therapeutics Market Size (Value) and Growth Rate
    Table 2013-2018E Global Microbiome Therapeutics Capacity and Growth Rate
    Table 2017 Global Microbiome Therapeutics Capacity (K Units) List (Company Segment)
    Table 2013-2018E Global Microbiome Therapeutics Sales (K Units) and Growth Rate
    Table 2017 Global Microbiome Therapeutics Sales (K Units) List (Company Segment)
    Table 2013-2018E Global Microbiome Therapeutics Sales Price (USD/Unit)
    Table 2017 Global Microbiome Therapeutics Sales Price (USD/Unit) List (Company Segment)
    Figure North America Capacity Overview
    Table North America Supply, Import, Export and Consumption (K Units) of Microbiome Therapeutics 2013-2018E 
    Figure North America 2013-2018E Microbiome Therapeutics Sales Price (USD/Unit)
    Figure North America 2017 Microbiome Therapeutics Sales Market Share
    Figure Europe Capacity Overview
    Table Europe Supply, Import, Export and Consumption (K Units) of Microbiome Therapeutics 2013-2018E 
    Figure Europe 2013-2018E Microbiome Therapeutics Sales Price (USD/Unit) 
    Figure Europe 2017 Microbiome Therapeutics Sales Market Share
    Figure China Capacity Overview
    Table China Supply, Import, Export and Consumption (K Units) of Microbiome Therapeutics 2013-2018E
    Figure China 2013-2018E Microbiome Therapeutics Sales Price (USD/Unit)
    Figure China 2017 Microbiome Therapeutics Sales Market Share
    Figure Japan Capacity Overview
    Table Japan Supply, Import, Export and Consumption (K Units) of Microbiome Therapeutics 2013-2018E
    Figure Japan 2013-2018E Microbiome Therapeutics Sales Price (USD/Unit)
    Figure Japan 2017 Microbiome Therapeutics Sales Market Share
    Figure Southeast Asia Capacity Overview
    Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Microbiome Therapeutics 2013-2018E
    Figure Southeast Asia 2013-2018E Microbiome Therapeutics Sales Price (USD/Unit)
    Figure Southeast Asia 2017 Microbiome Therapeutics Sales Market Share
    Figure India Capacity Overview
    Table India Supply, Import, Export and Consumption (K Units) of Microbiome Therapeutics 2013-2018E
    Figure India 2013-2018E Microbiome Therapeutics Sales Price (USD/Unit)
    Figure India 2017 Microbiome Therapeutics Sales Market Share
    Table Global 2013-2018E Microbiome Therapeutics Sales (K Units) by Type
    Table Different Types Microbiome Therapeutics Product Interview Price
    Table Global 2013-2018E Microbiome Therapeutics Sales (K Units) by Application
    Table Different Application Microbiome Therapeutics Product Interview Price
    Table Seres Therapeutics Information List
    Table Product Overview
    Table 2017 Seres Therapeutics Microbiome Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Seres Therapeutics Microbiome Therapeutics Business Region Distribution
    Table Assembly Biosciences Information List
    Table Product Overview
    Table 2017 Assembly Biosciences Microbiome Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Assembly Biosciences Microbiome Therapeutics Business Region Distribution
    Table Synthetic Biologics Information List
    Table Product Overview
    Table 2017 Synthetic Biologics Microbiome Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Synthetic Biologics Microbiome Therapeutics Business Region Distribution
    Table Interxon Information List
    Table Product Overview
    Table 2017 Interxon Microbiome Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Interxon Microbiome Therapeutics Business Region Distribution
    Table PureTech Information List
    Table Product Overview
    Table 2017 PureTech Microbiome Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 PureTech Microbiome Therapeutics Business Region Distribution
    Table Synlogic Information List
    Table Product Overview
    Table 2017 Synlogic Microbiome Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Synlogic Microbiome Therapeutics Business Region Distribution
    Table Enterome BioScience Information List
    Table Product Overview
    Table 2017 Enterome BioScience Microbiome Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Enterome BioScience Microbiome Therapeutics Business Region Distribution
    Table 4D Pharma Information List
    Table Product Overview
    Table 2017 4D Pharma Microbiome Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 4D Pharma Microbiome Therapeutics Business Region Distribution
    Table Second Genome Information List
    Table Product Overview
    Table 2017 Second Genome Microbiome Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Second Genome Microbiome Therapeutics Business Region Distribution
    Table AOBiome Information List
    Table Product Overview
    Table 2017 AOBiome Microbiome Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 AOBiome Microbiome Therapeutics Business Region Distribution
    Table C3 Jian Information List
    Table Rebiotix Information List
    Table MicroBiome Therapeutics LLC Information List
    Table Metabiomics Information List
    Table Ritter Pharmaceuticals Information List
    Table Symberix Information List
    Table OpenBiome Information List
    Table Azitra Information List
    Table Symbiotix Biotherapies Information List
    Table Osel Information List
    Table Metabogen Information List
    Figure Global 2018-2025 Microbiome Therapeutics Market Size (K Units) and Growth Rate Forecast
    Figure Global 2018-2025 Microbiome Therapeutics Market Size (Million USD) and Growth Rate Forecast
    Figure Global 2018-2025 Microbiome Therapeutics Sales Price (USD/Unit) Forecast
    Figure North America 2018-2025 Microbiome Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
    Figure China 2018-2025 Microbiome Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
    Figure Europe 2018-2025 Microbiome Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
    Figure Southeast Asia 2018-2025 Microbiome Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
    Figure Japan 2018-2025 Microbiome Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
    Figure India 2018-2025 Microbiome Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
    Table Global Sales Volume (K Units) of Microbiome Therapeutics by Type 2018-2025
    Table Global Consumption Volume (K Units) of Microbiome Therapeutics by Application 2018-2025
    Table Traders or Distributors with Contact Information of Microbiome Therapeutics by Region

Latest News

11-Aug-2018 | Electrical & Electronic Device

Samsung leads the pack, Smartphone Market in India Grows 29% In Third Quarter

The shipments of mobile in India are expected to reach the mark of 262 Million units till the fourth quarter arrives. Relying on the numbers, vendors dealing in mobile shipped approximately 80 Mill ...

18-Jul-2018 | Chemicals & Materials

It is Possible!! Can News Reports Be Automated?

Artificial intelligence is currently the hot topic of the town owing to its efficiency and quick work. It is a technology that is currently being used for a number of applications in the various se ...

26-Jun-2018 | Electrical & Electronic Device

Vodafone to Make Stronger Enterprise Portfolio Thus Bolstering Global Telecom Market

Vodafone India is seeking at the broadband segment to fortify its venture portfolio, said the Sunil Sood, the MD and CEO of the telecom company. The carriers had posted 2x development in the enterp ...

17-Apr-2018 | Food Service & Hospitality

Beneficiaries In Puducherry Don’t Use Subsidy To Purchase Food Grain

The Union Food Ministry has received a request from the administration of Puducherry for crediting the subsidy to the beneficiaries’ bank accounts rather than the system distributing subsidiz ...

22-Mar-2018 | Service

Indian SMEs Can Now Opt For WhatsApp Business App For Better Connectivity

WhatsApp, a “Facebook” owned mobile-based application, has introduced its innovative and efficient feature “WhatsApp Business App” ...